Stock report · Delisted · NYSE
Enzo Biochem Inc (ENZ)
0.54USD Delisted Final close · Jun 18, 2025
ENZ no longer trades. Enzo Biochem was delisted from the NYSE in June 2025.
All prices on this page are historical. The last trade was on June 18, 2025, at $0.54.
ENZ stock price history
Final trading statistics
- Final close
- $0.54
- Final trading day
- Jun 18, 2025
- Market cap at delisting
- $28.29M
- Shares outstanding
- 52.40M
- Final 52-week range
- $0.25 – $1.20
- Avg. volume (final 3 mo.)
- 292,725
- All-time high
- $91.57 · Jan 2000
- All-time low
- $0.26 · Apr 2025
- Return since IPO
- -94.8%
- Beta
- 1.16
- Book value / share
- $0.89
- Price / book
- 0.61
About Enzo Biochem Inc
Enzo Biochem was a life sciences company focused on labeling and detection technology, from DNA up to whole-cell analysis, in the U.S. and abroad. Its labels, dyes, antibodies, genomic probes, immunoassays, biochemicals and proteins helped researchers find and see biological targets during drug discovery and development.
Its products were used in cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. The company also licensed its technology. Customers included academic and clinical researchers, biotech and drug companies, and diagnostics makers.
Enzo was incorporated in 1976 and based in Farmingdale, New York. Its stock was delisted from the NYSE in June 2025, with the final trade on June 18, 2025 at $0.54.
- Exchange (former)
- NYSE
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Farmingdale, NY
- Employees
- 125
- IPO date
- June 12, 1980
- Delisted
- June 18, 2025
- SEC CIK
- 316253
Enzo Biochem financials before the delisting
The last 5 fiscal years Enzo Biochem reported as a public company, fiscal year ending July.
ENZ revenue and net income
ENZ earnings per share
ENZ annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $31.91M | −$26.1M | −$1.26 |
| FY2023 | $31.06M | $20.3M | — |
| FY2022 | $107.07M | −$22.6M | −$0.37 |
| FY2021 | $117.73M | $3.4M | $0.17 |
| FY2020 | $76.02M | −$33.9M | −$0.57 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Enzo Biochem stock FAQ
What happened to Enzo Biochem stock?
Enzo Biochem was delisted from the NYSE in June 2025. The final close was $0.54 on June 18, 2025.
Can I still buy ENZ stock?
No. ENZ is no longer listed on the NYSE or any other U.S. exchange; it was removed on June 18, 2025.
What was the last price of ENZ?
ENZ last closed at $0.54 on June 18, 2025, which valued the company at about $28.29M.
How did Enzo Biochem do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Enzo Biochem reported revenue of $31.91M and net income of −$26.1M.
When did Enzo Biochem go public?
Enzo Biochem shares started trading on June 12, 1980.
ENZ no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.